This HTML5 document contains 15 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:id

marcrel:aut

n4:id n6:id n8:id n9:id n10:id n11:id n12:id n13:id n14:id n15:id

dcterms:bibliographicCitation

Guièze Romain, Robbe Pauline, Clifford Ruth, Pereira Bruno, Timbs Adele, Dilhuydy Marie-Sarah, Cabes Maite, Ysebaert Loic, Burns Adam, Nguyen-Khac Florence, Davi Frédéric, Veronese Lauren, Combes Patricia, Le Garff-Tavernier Magali, Leblond Véronique, Merle-Béral Hélène, Alsolami Reem, Hamblin Angela, Mason Joanne, Hillmen Peter, Taylor Jenny, Knight Samantha J. L., Tournilhac Olivier, Schuh Anna. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL. Blood, 2015, 126 (18), pp.2110--2117. ⟨10.1182/blood-2015-05-647578⟩ Guièze Romain, Robbe Pauline, Clifford Ruth, Guibert Sophie, Pereira Bruno, Timbs Adele, Dilhuydy Marie-Sarah, Cabes Maite, Ysebaert Loic, Burns Adam, Nguyen-Khac Florence, Davi Frédéric, Veronese Lauren, Combes Patricia, Le Garff-Tavernier Magali, Leblond Véronique, Merle-Béral Hélène, Alsolami Reem, Hamblin Angela, Mason Joanne, Pettitt Andrew, Hillmen Peter, Taylor Jenny, Knight Samantha J. L., Tournilhac Olivier, Schuh Anna. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL. Blood, American Society of Hematology, 2015, 126 (18), pp.2110--2117. ⟨10.1182/blood-2015-05-647578⟩

dcterms:title

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

dc:date

2015

bibo:doi

10.1182/blood-2015-05-647578